The Lancet HIV

The Lancet HIV - ISSN 2352-3018
Source Normalized Impact per Paper (SNIP): 3.719 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 8.071 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 14.753 (2018) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 14.091 (2018) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volume 6
Issues: 12 issues
ISSN: 23523018
Editor-in-Chief: Hayward

Institutional Subscription

eJournal
This journal does not feature personal pricing and is not available for personal subscription.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.



Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges. The Lancet HIV is a journal for a new era in the history of HIV/AIDS.



The Lancet HIV builds on The Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.



Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.



Visit www.thelancet.com/hiv for more information.